Published in J Physiol on October 19, 1896
Temperature and excitability. J Physiol (1907) 1.17
A technique for anodally blocking large nerve fibres through chronically implanted electrodes. J Neurol Neurosurg Psychiatry (1980) 0.93
The effect of temperature on the functional activity of the upper cervical ganglion. J Physiol (1900) 0.89
The time relations of the photo-electric changes in the eyeball of the frog. J Physiol (1903) 31.79
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med (1990) 11.57
The delay of the electrical response of nerve to a second stimulus. J Physiol (1910) 9.35
A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med (1990) 7.92
A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med (2001) 7.59
Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol (2003) 5.71
An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA (1993) 5.43
HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med (1995) 5.22
Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. Nature (1987) 4.66
Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med (1995) 3.83
Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers. J Natl Cancer Inst (1996) 3.53
Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med (1994) 3.29
Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol (1997) 3.04
Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes. J Exp Med (1987) 3.02
Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med (1998) 2.95
HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet (1993) 2.71
Presentation of viral antigen controlled by a gene in the major histocompatibility complex. Nature (1990) 2.65
Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood (2001) 2.57
Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol (2001) 2.54
Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study. Cancer Res (1998) 2.21
Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. J Clin Oncol (1995) 2.02
Cytotoxic lymphocytes from rats depleted of thymus processed cells. Nat New Biol (1971) 2.02
Plasmacytoid dendritic cells are highly susceptible to human immunodeficiency virus type 1 infection and release infectious virus. J Virol (2001) 1.92
The time-relations of the photo-electric changes produced in the eyeball of the frog by means of coloured light. J Physiol (1904) 1.88
An effect of pactamycin on the initiation of protein synthesis in reticulocytes. Biochem Biophys Res Commun (1970) 1.79
Mechanisms of protection induced by attenuated simian immunodeficiency virus. II. Lymphocyte depletion does not abrogate protection. AIDS Res Hum Retroviruses (1998) 1.73
Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial. Ann Oncol (2013) 1.62
Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114. J Clin Oncol (2002) 1.62
Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria. Lancet (1995) 1.62
Chemotherapy of adenocarcinoma of the pancreas. Semin Oncol (1996) 1.59
Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy. J Clin Oncol (1993) 1.52
A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides. Eur J Immunol (1993) 1.48
Note on the so-called Tendon Reflex. J Physiol (1896) 1.46
A multicenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma. Cancer (1999) 1.41
Lymphography in carcinoma of the uterus. Clin Radiol (1972) 1.38
The human cytotoxic T cell response to influenza A vaccination. Clin Exp Immunol (1981) 1.37
Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection. AIDS (1998) 1.35
Role of lymphography in carcinoma of the prostate. Br Med J (1975) 1.34
Observations on the growth of tumours in lymph nodes changing from normal to abnormal while remaining opacified after lymphography. Clin Radiol (1968) 1.31
Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes. Eur J Immunol (1992) 1.29
The role of computed tomography in the management of testicular teratoma. Clin Radiol (1979) 1.28
The electrical response of nerve to two stimuli. J Physiol (1899) 1.27
The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans (1992) 1.23
delta 9-tetrahydrocannabinol in clinical oncology. JAMA (1981) 1.23
The value of lymphography to the radiotherapist. Clin Radiol (1969) 1.20
Programmed death (PD)-1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1-infected individuals. Clin Exp Immunol (2009) 1.20
Chlorhexidine prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: a randomized double-blind trial. Oral Surg Oral Med Oral Pathol (1990) 1.19
On the Electrical Organ of the Skate. J Physiol (1888) 1.13
Immunogenic HIV variant peptides that bind to HLA-B8 can fail to stimulate cytotoxic T lymphocyte responses. J Immunol (1995) 1.12
The submaximal electrical response of nerve to a single stimulus. J Physiol (1902) 1.09
Immunohistochemical analysis of Bcl-2 family proteins in adenocarcinomas of the stomach. Am J Pathol (1996) 1.08
HLA-C and guttate psoriasis. Br J Dermatol (2000) 1.08
A point mutation in CD45 may be associated with an increased risk of HIV-1 infection. AIDS (2001) 1.08
Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114. J Clin Oncol (1997) 1.07
Identification of human herpesvirus 8-specific cytotoxic T-cell responses. J Virol (1999) 1.07
Current results of the screening program at the Division of Cancer Treatment, National Cancer Institute. Eur J Cancer (1981) 1.07
On the Electrical Organ of the Skate: Part II. J Physiol (1889) 1.06
Cutaneous seeding of pancreatic cancer by skinny-needle aspiration biopsy. Arch Intern Med (1980) 1.05
Treatment of metastatic renal cell carcinoma with coumarin (1,2-benzopyrone) and cimetidine: a pilot study. J Clin Oncol (1987) 1.04
Phase II trial of 5-fluorouracil plus eniluracil in patients with advanced pancreatic cancer: a Southwest Oncology Group study. Ann Oncol (2002) 0.99
Phase II trial of paclitaxel and granulocyte colony-stimulating factor in patients with pancreatic carcinoma: a Southwest Oncology Group study. J Clin Oncol (1997) 0.98
Lymphography in carcinoma of the ovary. Proc R Soc Med (1971) 0.97
Phase II trial of dimethyltriazenoimidazole carboxamide in patients with metastatic carcinoid. A Southwest Oncology Group study. Cancer (1994) 0.97
Lymphography in malignant disease of the urinary tract. Proc R Soc Med (1970) 0.97
p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status. Mod Pathol (1999) 0.96
Higher levels of activation markers and chemokine receptors on T lymphocytes in the cervix than peripheral blood of normal healthy women. J Reprod Immunol (2001) 0.96
Immunogenicity of the yeast recombinant p17/p24:Ty virus-like particles (p24-VLP) in healthy volunteers. Vaccine (1995) 0.95
Immune responses and reconstitution in HIV-1 infected individuals: impact of anti-retroviral therapy, cytokines and therapeutic vaccination. Immunol Lett (2001) 0.95
Phase-II trial of tamoxifen in advanced breat cancer. Cancer Chemother Pharmacol (1979) 0.95
Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: a prospective, randomized trial. J Clin Oncol (1995) 0.94
Tetracycline and quinacrine in the control of malignant pleural effusions. A randomized trial. Cancer (1978) 0.94
Lymphocyte proliferation and cytotoxic assays using flat-bed scintillation counting. J Immunol Methods (1987) 0.93
Phase II trial of streptozotocin, mitomycin-C and 5-fluorouracil (SMF) in the treatment of advanced pancreatic cancer. Cancer (1978) 0.93
NKG2C+ NK cells are enriched in AIDS patients with advanced-stage Kaposi's sarcoma. J Virol (2006) 0.93
Loss of the CD56hiCD16- NK cell subset and NK cell interferon-gamma production during antiretroviral therapy for HIV-1: partial recovery by human growth hormone. Clin Exp Immunol (2003) 0.92
Phase I clinical trial of spirogermanium. Cancer Treat Rep (1981) 0.91
Clinical trials with antiemetic agents in cancer patients receiving chemotherapy. J Clin Pharmacol (1982) 0.91
Probable clonal origin of acute myeloblastic leukemia following radiation and chemotherapy of colon cancer. Blood (1978) 0.91
Lack of a graft-versus-leukemia effect in an immunologically privileged sanctuary site. Bone Marrow Transplant (1994) 0.91
The exon A (C77G) mutation is a common cause of abnormal CD45 splicing in humans. J Immunol (2001) 0.91
Lymphography in the management of urinary tract tumours. Br J Urol (1968) 0.90
A phase I trial in HIV negative healthy volunteers evaluating the effect of potent adjuvants on immunogenicity of a recombinant gp120W61D derived from dual tropic R5X4 HIV-1ACH320. Vaccine (2000) 0.89
An introduction to current controversies in cancer management: stage I testicular cancer-a case in point. Cancer Treat Rep (1982) 0.89
The effect of local injury upon the excitatory electrical response of nerve. J Physiol (1902) 0.89
Early initiation of chronic dialysis: role of incremental dialysis. Perit Dial Int (1997) 0.88
Adjuvant therapy in colorectal carcinoma. Semin Oncol (1991) 0.88
Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: clinical and angiogenic correlations. Ann Oncol (2003) 0.88
Evaluation of combination chemotherapy and phase II agents in pancreatic adenocarcinoma. A Southwest Oncology Group study. Cancer (1993) 0.87
Biologic-response modifiers and adjuvant chemotherapy: consideration of selected preclinical investigations in relation to clinical potential. Recent Results Cancer Res (1982) 0.87
Amplified antigen-specific immune responses in HIV-1 infected individuals in a double blind DNA immunization and therapy interruption trial. Vaccine (2011) 0.87
Chemotherapy of colorectal carcinoma. Semin Oncol (1976) 0.87
5-Fluorouracil and folinic acid in the treatment of metastatic colorectal cancer: a randomized comparison. A Southwest Oncology Group Study. J Clin Oncol (1987) 0.86
Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes. Nature (1989) 0.86
Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy. Invest New Drugs (1988) 0.85
Immune correlates of protection from HIV and AIDS - more answers but yet more questions. Immunol Today (1999) 0.85
Mitomycin C: experience in the United States, with emphasis on gastric cancer. Cancer Chemother Pharmacol (1978) 0.84
Synergistic effect of 5-fluorouracil and N-(phosphonacetyl)-L-aspartate on cell growth and ribonucleic acid synthesis in human mammary carcinoma. Biochem Pharmacol (1981) 0.83
The stability between two HIV-1 RNA measurements one year apart and the relationship with HIV subtype in rural Uganda. Int J STD AIDS (2001) 0.83